(RTTNews.com) - Global eye health company, Bausch & Lomb Friday said that its subsidiary ISTA Pharmaceuticals, Inc.,(ISTA) has agreed to pay about $34 million to resolve charges against it for introducing its anti-inflammatory Xibrom for unauthorized uses ...
Bausch & Lomb Said to Be Near $9 Billion Sale to Valeant
New York Times
Warburg Would Get Threefold Return in Bausch Transaction
Related articles »